End-of-day quote
Other stock markets
|
||
- USD | - |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 03 | AIB GROUP : Stronger revenue growth and a benign cost of risk |
Sales 2024 * | 4.56B 4.94B | Sales 2025 * | 4.34B 4.71B | Capitalization | 12.64B 13.7B |
---|---|---|---|---|---|
Net income 2024 * | 1.76B 1.91B | Net income 2025 * | 1.56B 1.69B | EV / Sales 2024 * | 2.77 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.91 x |
P/E ratio 2024 * |
7.28
x | P/E ratio 2025 * |
7.57
x | Employees | - |
Yield 2024 * |
5.76% | Yield 2025 * |
6.1% | Free-Float | 68.01% |
Latest transcript on Allied Irish Banks PLC
Managers | Title | Age | Since |
---|---|---|---|
Colin Hunt
CEO | Chief Executive Officer | 54 | 15-12-31 |
Donal Galvin
DFI | Director of Finance/CFO | 50 | 13-08-31 |
Graham Fagan
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fergal O’Dwyer
BRD | Director/Board Member | 64 | 21-01-21 |
James Pettigrew
CHM | Chairman | 65 | 21-10-27 |
Brendan McDonagh
BRD | Director/Board Member | 66 | 16-10-26 |
1st Jan change | Capi. | |
---|---|---|
+19.12% | 582B | |
+18.87% | 313B | |
+15.71% | 251B | |
+21.74% | 209B | |
+19.14% | 180B | |
+24.16% | 169B | |
+9.58% | 164B | |
+11.18% | 154B | |
-10.40% | 140B |